Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease multiple sclerosis
Symptom C0235946|brain atrophy
Sentences 10
PubMedID- 25756363 Background: the aim of the present meta-analysis was to evaluate the effect of disease-modifying drugs (dmd) on brain atrophy in patients with relapsing-remitting multiple sclerosis (rrms) using available randomized-controlled trial (rct) data.
PubMedID- 25941537 Background: studies have shown a relationship between increased iron content and clinical progression, cognitive impairment, and brain atrophy in patients with multiple sclerosis.
PubMedID- 23730365 Over the last decade brain atrophy in patients with multiple sclerosis (ms) has found increasing interest.
PubMedID- 26419927 Fingolimod (fty720) reduces relapses, disability progression, and brain atrophy in patients with relapsing-remitting multiple sclerosis (ms) .
PubMedID- 26362893 Increased albumin quotient (qalb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
PubMedID- 22899026 Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis.
PubMedID- 21414412 Regional brain atrophy in children with multiple sclerosis.
PubMedID- 24022394 In recent years, it has become increasingly evident that multiple sclerosis (ms) leads to clinically relevant brain atrophy in the disease course and that this process may begin early.1–10 the clinical correlate of brain atrophy, for example, can be a secondary chronic progression or pure neuropsychological discomfort or symptoms.
PubMedID- 24264439 brain atrophy: an in-vivo measure of disease activity in multiple sclerosis.
PubMedID- 23650470 A recent nih study by borges et al demonstrated a decrease in the rate of brain atrophy in patients with multiple sclerosis on daclizumab compared to placebo by assessing brain volume on t1-weighted and t2-flair mri sequences using toads-cruise program.

Page: 1